Skip to main content
John Concato, MD, Internal Medicine, New Haven, CT

John Concato MD


Professor, Internal Medicine, Yale University School of Medicine

Join to view full profile
  • 333 Cedar StNew Haven, CT 06510

Dr. Concato is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Concato is an Adjunct Professor of Medicine at Yale School of Medicine. He joined the FDA in 2019 and from 2020-2024 was an Associate Director for the Office of Medical Policy, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), overseeing Real-World Evidence Analytics. He worked with other CDER offices, FDA centers, and external entities to promote understanding of, and opportunities related to, use of real-world data (RWD) and real-world evidence (RWE). His duties included directing CDER’s RWE Program, serving as Chair of RWE Subcommittee, supporting Agency processes related to RWD/RWE, and interacting with interested parties.

    Under Dr. Concato’s leadership, CDER published eight guidance documents on RWD/RWE during 2021-2024, representing a first-generation portfolio of recommendations on data sources, study design, and regulatory considerations. In parallel, more than 25 research projects were funded to improve the reliability or use of RWD, better understand study designs that generate RWE, or develop specific methodological “tools.” He led initiatives leading to a new Advancing RWE Program and the first CDER RWE Annual Report. His presentations and publications are cited frequently.

    Dr. Concato was previously an investigator, mentor, administrator, and clinician at Yale School of Medicine and Veterans Affairs (VA) Connecticut Healthcare System from 1992-2019. As an internist and epidemiologist, he acquired experience in methodological and applied topics involving study design and data analysis in patient-oriented research and medical product evaluation. His work included research evaluating the effectiveness of screening programs and other topics, launching the Million Veteran Program genomic biobank, comparing results of non-interventional studies and randomized trials to inform ongoing discussions of real-world data and evidence, and serving as the founding director of the VA Clinical Epidemiology Research Center.

Education & Training

  • Yale-New Haven Hospital
    Yale-New Haven HospitalFellowship, Robert Wood Johnson Clinical Scholar, 1989 - 1991
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 1985 - 1989
  • New York University School of Medicine
    New York University School of MedicineClass of 1985

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 1989 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • AUDIT‐C and ICD Codes as Phenotypes for Harmful Alcohol Use: Association with ADH1B Polymorphisms in Two U.S. Populations  
    David A Fiellin, William C Becker, Joel Gelernter, Henry R Kranzler, Ning Sun, John Concato, Addiction

Press Mentions

  • FDA Blazes Path for ‘Real-World’ Evidence as Proof of Efficacy
    FDA Blazes Path for ‘Real-World’ Evidence as Proof of EfficacyMay 11th, 2021
  • Report Casts Fresh Doubts on Prostate Cancer Testing
    Report Casts Fresh Doubts on Prostate Cancer TestingJanuary 10th, 2006
  • Report Casts Fresh Doubts on Prostate Cancer Testing
    Report Casts Fresh Doubts on Prostate Cancer TestingJanuary 10th, 2006

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: